ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

16.50
0.00 (0.00%)
17 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.50 16.00 17.00 16.50 16.50 16.50 22,804 07:36:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.81 15.05M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 16.50p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £15.05 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.81.

Optibiotix Health Share Discussion Threads

Showing 20251 to 20273 of 147750 messages
Chat Pages: Latest  822  821  820  819  818  817  816  815  814  813  812  811  Older
DateSubjectAuthorDiscuss
31/1/2017
20:31
Well that was a day to forget. Blue is so much better, think about it shares, cars, movies. Although Hunt for Red October wasn't bad.. :)
1bokke
31/1/2017
18:07
What would be nice is if some of these celebrities are seen sipping the shakes and munching the snack bars!
misconduct
31/1/2017
18:04
£130 an hour! Me thinks I'll have to turn the table round on this ;-)
elrico
31/1/2017
15:03
But we do know for certain that (at least) two multinational consumer goods companies are looking to produce products using OPTI's IP.

Take your pick...

Mondelez,
Kraft,
Coca-Cola,
Nestle,
Pepsico,
P&G,
Johnson&Johnson,
Mars,
Danone,
Tata,
General Mills,
Kellogg's,
Unilever,
Tate & Lyle,
DuPont,
GlaxoSmithKline,

someuwin
31/1/2017
14:50
Just strong rumours at the moment.

That's why the share price will rocket when / if we get confirmation.

someuwin
31/1/2017
14:46
Do we know for sure that tata and P & G are on board, we only have TW's word, are they 100%
neftanikoff
31/1/2017
13:02
With a bit of "Ohara Twist" thrown in
kipper1960
31/1/2017
12:20
No problem mouse. I would love to know that too but I definitely won't be given any info! So many things coming to the boil now, hopefully we get something soon! I think us LTH deserve it!
primal123
31/1/2017
12:12
Thanks Primal.
Could you drop her a line to ask if we will get an RNS soon on any of the following?

Tata
P&G
Boots
Slimfast
Nizo
VLG
DSM
J&J (skin)
Skin flotation.

Have I missed anything?

When the news comes it should be exciting.......

mouse20
31/1/2017
12:04
I emailed Anna to see if we would get any form of RNS on the presentations this week, the response is below: "We were not planning to releasing the abstracts. ProBiotia is a very scientific conference so the posters are designed for that audience. We gave relatively detailed information on what the abstracts were about in the release on 12 January so I don't really think we need to announce anything else."
primal123
31/1/2017
11:17
I am in agreement Someuwin; Yes I, too, expect follow-on developments to trigger share price rise; I suppose I'm simply suggesting (as you are): don't expect fireworks this week, or any week for that matter, in absence of an igniter; but then that's what we're all saying - and we're in for the long(ish!) haul.
owenmo
31/1/2017
11:08
Owenmo - there's a world of difference between last year's PR company organised investor presentation, and this year's presentation at a major industry conference...

"ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiota focused food and pharma industries. The conference is world renowned as a key meeting place for a community of scientists and business leaders who want to translate science into new products in the growing supplements and ingredients market."

Will this lead to a big rise in sp? probably not. But as they've explained, these publications will support the launch of their new cardiovascular products.

i.e once they have done the official presentations they can get on and tell the world about their new Cholesterol and blood pressure products. And that SHOULD lead to a big rise in the share price

someuwin
31/1/2017
10:43
I may be behind the curve publishing this here now, but anyway, this is Berlin on Friday according to the website quoted in an earlier post.

SOH is one of only two people given the opportunity to make an oral presentation (i.e. the best two as reviewed by the Science Committee) It starts Friday at 11:15 European time, and they get 15 mins each).

Stephen will present his Scientific Frontiers abstract:

An assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum LP-LDL in adults with normal to mildly elevated cholesterol

OBJECTIVE: This aim of this study was to investigate the cholesterol reducing capacity of Lactobacillus plantarum LP-LDL in 49 healthy adults with normal to mildly elevated cholesterol. LP-LDL was selected after screening 4000 strains for high bile salt hydrolase (BSH) and high in vitro cholesterol reduction activity. Primary efficacy outcomes included effect on blood lipids (TC, LDL-C, HDL-C, TAG) and product safety (inflammatory biomarkers, occurrence of gastrointestinal side effects). Secondary outcomes included blood pressure, immune biomarkers and gut microbiome changes.

METHODS: The study was conducted in a parallel, double blind placebo controlled, randomised design. The active group ingested 2×109 CFU encapsulated L. plantarum LP-LDL twice daily for 12 weeks. The placebo group received identical capsules without the probiotic. Samples were provided at baseline, 6, 12 and 16 weeks (washout).

RESULTS: LDL-C was significantly lower in the active group with baseline TC<5mM (13.9%, P=0.030; 0-12weeks) and the TC6mM group (36.7%, P=0.045; 0-6weeks) compared to the placebo. Active treatment in the over 60yrs population significantly increased HDL-C levels (14.7%, P=0.03) and reduced TAG (53.9%, P=0.02). A statistically significant reduction in systolic blood pressure was also observed in the active study group (6.6%, P=0.003; 6-12week period). LP-LDL ingestion had no impact on inflammatory biomarkers and gastrointestinal parameters.

CONCLUSIONS: The results of this study confirmed the safety of L. plantarum LP-LDL and demonstrated that it can positively impact on cardiovascular risk lipid profiles and blood pressure. Our results, in an unoptimised product, in healthy adults, suggest efficacy similar or greater to 1.5-2.4g/day plant sterols/stanols.

There will also be two 'posters' from OPTI (out of 17):

4 – Development of a synergistic synbiotic for Lactobacillus plantarum LP-LDL targeting cholesterol reduction
Dr Sofia Kolida, OptiBiotix Health

12 – An assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum LP-LDL in adults with normal to mildly elevated cholesterol
Stephen OHara, OptiBiotix Health

Best wishes - Mike
p.s. I don't know if OPTI will RNS the contents of the presentations in layman's language, but I suspect they might.

spike_1
31/1/2017
10:42
A case of deja vu all over again? This time last year witnessed 100p share price in prospect - not least in anticipation of SOH (Feb?) Press Briefing in London Hotel that we all got excited about? (I know I was very tempted to travel for it; a bonus would have been to have met some of you guys) Is there anything in next Friday's presentation not yet in public domain? So, next week, in absence of the all-too-scarce ground-breaking RNS, is it a re-run of "as you were!" next week?
owenmo
31/1/2017
10:40
How good would SOH feel if he could stand up on Friday and say " I'm really pleased that we announced yesterday ... boots... Tata... " hint hint Stephen..
1bokke
31/1/2017
10:39
They do Parob.
elrico
31/1/2017
10:38
just sold my PMO to top up my holding here this morning
humphries1
31/1/2017
10:35
OPTI just now on twitter:

OptiBiotix Health ‏@OptiBiotix 39s40 seconds ago
@GoFigureDiet are listed on page 7 under 'Hot Buys - True Health's top picks' #slimbiome

They must read this bulletin board!

parob
31/1/2017
10:34
Commenting, Stephen O'Hara, CEO of OptiBiotix said: "These publications, at a major conference, will support the launch of a range of cardiovascular products to reduce LDL cholesterol, blood pressure and cardiovascular risk, planned for the spring of 2017. The publications will provide the scientific evidence for sales and marketing literature, which will help with product differentiation and higher margins. In order to provide us with wider coverage of our scientific advances in both the scientific and mainstream news media, we have appointed a specialist scientific PR company, Vane Percy & Roberts to help with this."
someuwin
31/1/2017
10:11
some,
I personally think on-line limits can be deceiving
Much prefer to call somebody and actually find out whats available and at what price in the "real" world.
Sometimes the maximum will only be 10k shares available, sometimes 20k shares, occasionally 50k shares, sometimes T20 and sometimes only T10
Each to their own though hey :)

judijudi
31/1/2017
10:03
There's loads of shares available with ALL brokers (depending on how much you are prepared to pay). I post the ONLINE quote limits as a rough and ready indication of demand.
someuwin
31/1/2017
09:58
Loads of shares available with my broker
judijudi
31/1/2017
09:51
Can get an online quote for £2k. but not £3k.
someuwin
Chat Pages: Latest  822  821  820  819  818  817  816  815  814  813  812  811  Older

Your Recent History

Delayed Upgrade Clock